From cryptic chromosomal lesions to pathologically relevant genes: Integration of SNP-array with gene expression profiling in myelodysplastic syndrome with normal karyotype

Genes Chromosomes and Cancer

Volumn 51, Issue 5, 2012, Pages 419-428

  Merkerova, Michaela Dostalova ^a   Bystricka, Dagmar ^b   Belickova, Monika ^a   Krejcik, Zdenek ^a   Zemanova, Zuzana ^b   Polak, Jaroslav ^a   Hajkova, Hana ^a   Brezinova, Jana ^a   Michalova, Kyra ^a,b   Cermak, Jaroslav ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CD34 ANTIGEN; PROTEIN; TRIB3 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHROMOSOME 17Q; CHROMOSOME 20Q; CHROMOSOME 3Q; CHROMOSOME 7Q; CHROMOSOME DAMAGE; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION PROFILING; GENOTYPE; GRANULOCYTE; HUMAN; KARYOTYPE; MALE; MICROARRAY ANALYSIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; UNIPARENTAL DISOMY; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HUMANS; KARYOTYPE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84857997094     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.21927     Document Type: Article

References (24)

1. Bajaj R, Xu F, Xiang B, et al. 2001. Evidence-based genomic diagnosis characterized chromosomal and cryptic imbalances in 30 elderly patients with myelodysplastic syndrome and acute myeloid leukemia. Mol Cytogenet 4: 3.
2. Bakshi R, Hassan MQ, Pratap J, et al. 2010. The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes. J Cell Physiol 225: 569-576.
3. Bejar R, Stevenson K, Abdel-Wahab O, et al. 2011. Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med 364: 2496-2506.
4. Cermák J, Belicková M, Krejcová H, et al. 2005. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia. Leuk Res 29: 371-379.
5. Cilloni D, Renneville A, Hermitte F, et al. 2009. Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: A European leukemianet study. J Clin Oncol 27: 5195-5201.
6. Fitzgibbon J, Smith LL, Raghavan M, et al. 2005. Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias. Cancer Res 65: 9152-9154.
7. Gondek LP, Tiu R, O'Keefe CL, et al. 2008. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. Blood 111: 1534-1542.
8. Gorletta TA, Gasparini P, D'Elios MM, et al. 2005. Frequent loss of heterozygosity without loss of genetic material in acute myeloid leukemia with a normal karyotype. Genes Chromosomes Cancer 44: 334-337.
9. Haase D. 2008. Cytogenetic features in myelodysplastic syndromes. Ann Hematol 87: 515-526.
10. Heinrichs S, Kulkarni RV, Bueso-Ramos CE, et al. 2009. Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics. Leukemia 23: 1605-1613.
11. Kralovics R, Guan Y, Prchal JT. 2002. Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera. Exp Hematol 30: 229-236.
12. Makishima H, Maciejewski JP. 2011. Pathogenesis and consequences of uniparental disomy in cancer. Clin Cancer Res 17: 3913-3923.
13. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
14. Mohamedali A, Gäken J, Twine NA, et al. 2007. Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes. Blood 110: 3365-3373.
15. Mohamedali AM, Smith AE, Gaken J, et al. 2009. Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndrome. J Clin Oncol 27: 4002-4006.
16. Mufti GJ. 2004. Pathobiology, classification, and diagnosis of myelodysplastic syndrome. Best Pract Res Clin Haematol 17: 543-557.
17. Raghavan M, Lillington DM, Skoulakis S, et al. 2005. Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Cancer Res 65: 375-378.
18. Serrano E, Carnicer MJ, Orantes V, et al. 2008. Uniparental disomy may be associated with microsatellite instability in acute myeloid leukemia (AML) with a normal karyotype. Leuk Lymphoma 49: 1178-1183.
19. Shaffer LG, Slovak ML, Campbell LJ, editors. 2009. An international System for Human Cytogenetic Nomenclature. Basel: S. Karger.
20. Starczynowski DT, Vercauteren S, Sung S, et al. 2011. Copy number alterations at polymorphic loci may be acquired somatically in patients with myelodysplastic syndromes. Leuk Res 35: 444-447.
21. Suzuki S, Hashino S, Yoshida S, et al. 2002. del11(p11-13) with overexpression of Wilms' tumor gene during leukemic transformation of myelodysplastic syndrome. Ann Hematol 81: 605-608.
22. Tiu RV, Gondek LP, O'Keefe CL, et al. 2011. Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies. Blood 117: 4552-4560.
23. Vasikova A, Belickova M, Budinska E, et al. 2010. A distinct expression of various gene subsets in CD34+ cells from patiens with early and advanced myelodysplastic syndrome. Leuk Res 34: 1566-1572.
24. Yokoyama T, Nakamura T. 2011. Tribbles in disease: Signaling pathways important for cellular function and neoplastic transformation. Cancer Sci 102: 1115-1122.